This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Temasek Life Sciences Laboratory Limited. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Alexander Emelyanov: Innovator in Genetic Engineering
Introduction
Alexander Emelyanov is a prominent inventor based in Singapore, known for his significant contributions to the field of genetic engineering. With a total of five patents to his name, he has made remarkable advancements that have implications in transgenic research and cancer studies.
Latest Patents
One of his latest patents is the "LexA-based chemical-inducible gene expression system for use in transgenic animals." This invention relates to a chemical-inducible system and methods for use in transgenic animals. It specifically involves a chimeric transcription factor that binds to a ligand, functioning in a ligand-dependent manner to induce the expression of genes of interest under the control of a synthetic operator-promoter sequence. The expression of these genes can be tightly controlled by the addition or removal of the ligand.
Another notable patent is the "Fish cancer model," which is directed towards fish whose genome has integrated an oncogenic nucleic acid operably linked to a promoter. This invention provides methods for creating these fish and outlines their use in screening for drugs or agents that modulate oncogene-mediated neoplastic or hyperplastic transformation, as well as sensitivity to chemotherapy or radiation therapy. Additionally, it includes methods for making immortal tumor cell lines and their applications.
Career Highlights
Alexander Emelyanov is currently associated with Temasek Life Sciences Laboratory Limited, where he continues to push the boundaries of genetic research. His work has been instrumental in developing innovative solutions that address critical challenges in biotechnology.
Collaborations
He has collaborated with notable colleagues, including Sergey Parinov and Nam-Hai Chua, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
In summary, Alexander Emelyanov is a distinguished inventor whose work in genetic engineering has led to significant advancements in transgenic systems and cancer research. His contributions continue to influence the field and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile